These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 27520904)
21. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Ravikiran M; Bhansali A; Ravikumar P; Bhansali S; Dutta P; Thakur JS; Sachdeva N; Bhadada S; Walia R Diabetes Res Clin Pract; 2010 Aug; 89(2):181-8. PubMed ID: 20381187 [TBL] [Abstract][Full Text] [Related]
22. Global Prevalence of Metabolic Syndrome in Schizophrenia Patients: A Systematic Review and Meta-Analysis. Salari N; Maghami N; Ammari T; Mosafer H; Abdullahi R; Rasoulpoor S; Babajani F; Mahmodzadeh B; Mohammadi M J Prev (2022); 2024 Jul; ():. PubMed ID: 39048892 [TBL] [Abstract][Full Text] [Related]
23. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. De Hert MA; van Winkel R; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J Schizophr Res; 2006 Mar; 83(1):87-93. PubMed ID: 16481149 [TBL] [Abstract][Full Text] [Related]
24. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study. Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308 [TBL] [Abstract][Full Text] [Related]
25. The association between rehabilitation programs and metabolic syndrome in chronic inpatients with schizophrenia. Lin YC; Lai CL; Chan HY Psychiatry Res; 2018 Feb; 260():227-232. PubMed ID: 29216485 [TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome in drug-naïve and drug-free patients with schizophrenia and in their siblings. Enez Darcin A; Yalcin Cavus S; Dilbaz N; Kaya H; Dogan E Schizophr Res; 2015 Aug; 166(1-3):201-6. PubMed ID: 26004686 [TBL] [Abstract][Full Text] [Related]
27. Metabolic syndrome among urban Indian young adults: prevalence and associated risk factors. Manjunath D; Uthappa CK; Kattula SR; Allam RR; Chava N; Oruganti G Metab Syndr Relat Disord; 2014 Sep; 12(7):381-9. PubMed ID: 25007135 [TBL] [Abstract][Full Text] [Related]
28. Comparison of metabolic syndrome prevalence in patients with schizophrenia and bipolar I disorder. Nayerifard R; Bureng MA; Zahiroddin A; Namjoo M; Rajezi S Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S411-S416. PubMed ID: 28927969 [TBL] [Abstract][Full Text] [Related]
29. Metabolic syndrome in drug naïve schizophrenic patients. Anjum S; Bathla M; Panchal S; Singh GP; Singh M Diabetes Metab Syndr; 2018; 12(2):135-140. PubMed ID: 29191416 [TBL] [Abstract][Full Text] [Related]
30. Association between anxiety and metabolic syndrome: A systematic review and meta-analysis of epidemiological studies. Tang F; Wang G; Lian Y Psychoneuroendocrinology; 2017 Mar; 77():112-121. PubMed ID: 28027497 [TBL] [Abstract][Full Text] [Related]
31. Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies. Valipour G; Saneei P; Esmaillzadeh A J Clin Endocrinol Metab; 2014 Oct; 99(10):3863-72. PubMed ID: 25050991 [TBL] [Abstract][Full Text] [Related]
32. [Prevalence of metabolic syndrome in Spanish patients with schizophrenia and overweight. The CRESSOB Study]. Gutiérrez-Rojas L; Azanza JR; Bernardo M; Rojo L; Mesa F; Martínez-Ortega JM Actas Esp Psiquiatr; 2014; 42(1):9-17. PubMed ID: 24504989 [TBL] [Abstract][Full Text] [Related]
33. Alcohol use disorders in patients with schizophrenia: comparative study with general population controls. Kumar CN; Thirthalli J; Suresha KK; Arunachala U; Gangadhar BN Addict Behav; 2015 Jun; 45():22-5. PubMed ID: 25634440 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of metabolic syndrome among inpatients with schizophrenia. Boke O; Aker S; Sarisoy G; Saricicek EB; Sahin AR Int J Psychiatry Med; 2008; 38(1):103-12. PubMed ID: 18624022 [TBL] [Abstract][Full Text] [Related]
35. Metabolic syndrome and schizophrenia from integrative medicine perspective. Maslov B; Jakovljević M; Crncević Z; Ostojić L; Marcinko D; Babić D; Korsić M Psychiatr Danub; 2008 Sep; 20(3):384-9. PubMed ID: 18827767 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta-analysis. Sun C; Qin W; Zhang YH; Wu Y; Li Q; Liu M; He CD Int J Rheum Dis; 2017 Aug; 20(8):917-928. PubMed ID: 28851080 [TBL] [Abstract][Full Text] [Related]
37. Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review. Mabry RM; Reeves MM; Eakin EG; Owen N Diabet Med; 2010 May; 27(5):593-7. PubMed ID: 20536958 [TBL] [Abstract][Full Text] [Related]
38. The prevalence and moderators of clinical pain in people with schizophrenia: a systematic review and large scale meta-analysis. Stubbs B; Mitchell AJ; De Hert M; Correll CU; Soundy A; Stroobants M; Vancampfort D Schizophr Res; 2014 Dec; 160(1-3):1-8. PubMed ID: 25458569 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of metabolic syndrome among patients with depressive disorder admitted to a psychiatric inpatient unit: A comparison with healthy controls. Grover S; Nebhinani N; Chakrabarti S; Avasthi A Asian J Psychiatr; 2017 Jun; 27():139-144. PubMed ID: 28558888 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics. Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]